Neurovascular Thrombectomy Market, Size, Share, Opportunities and Forecast, 2020-2027

SKU: DHC271 | Last Updated On: Jun 10 2020 | No. of Pages: 192 | Available Formats

> Global Neurovascular Thrombectomy Market Expected to reach a high CAGR of 6.8% By 2027: DataM Intelligence

Global Neurovascular Thrombectomy Market is segmented By Product Type (Aspiration Thrombectomy Devices, Mechanical Thrombectomy Devices, Ultrasonic Thrombectomy Devices, Others), By End User (Hospitals, Neuro-Catheterization Labs, Specialized Neurosurgery Centers), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2020-2027

 

Market Overview

The Global Neurovascular Thrombectomy Market is expected to grow at a CAGR of 6.8% during the forecasting period (2020-2027).

Thrombectomy is a surgical procedure to remove the blood clots formed in the blood vessel.  Neurovascular thrombectomy is also known as cerebral thrombectomy is used to retrieve or destroy the blood clots in the cerebral region. The blockage in blood vessels of the brain is due to various reasons, such as atheroma, an embolus, or a thrombus of one or more arteries. The blood clot formed may lead to draining or leakage of blood into the brain, if left untreated. According to the World Health Organization (WHO), 15 million people suffer from stroke worldwide each year. Of these, five million dies and another five million are permanently disabled. Neurovascular thrombectomy devices are used to remove blood clots in the large blood vessels and to re-establish normal blood flow to the brain and prevent stroke.

**Source: DataM Intelligence Analysis (2019)

Market Dynamics

The neurovascular thrombectomy market growth is driven by several factors, such as the rising prevalence of ischemic stroke and technological advancement.

Stroke is ranked as the second leading cause of death worldwide with an annual mortality rate of about 5.5 million. Not only does the burden of stroke lies in the high mortality but the high morbidity also results in up to 50% of survivors being chronically disabled. Thus, stroke is a disease of immense public health importance with serious economic and social consequences. According to a report from the Global Burden of Disease (GBD) 2016 Lifetime Risk of Stroke Collaborators, the estimated global lifetime risk of stroke in 2016 for those aged 25 years or older was 24·9%, an increase from 22·8% in 1990. The estimate includes an almost equal risk of stroke among women and men and an 18·3% risk of ischemic stroke and 8·2% risk of hemorrhagic stroke. Mechanical neurovascular thrombectomy is indicated for patients with acute ischemic stroke due to a large artery occlusion in the anterior circulation who can be treated within 24 hours of the time last known to be well.

Catheter-based blood clot removal a decade ago was a standard of care for acute coronary revascularization, but declined rapidly after several large trials showed no benefit. However, today, thrombectomy is seeing increasing usage in new therapeutic areas to treat acute stroke, pulmonary embolism, deep vein thrombosis and venous thromboembolism. New technologically advanced products such as acoustic pulse generating ultrasonic devices that quickly resolve pulmonary embolism, deep vein thrombosis and peripheral arterial occlusions are coming into the market. Devices nowadays come with touch screen that allows physicians to easily monitor and independently manage two devices simultaneously and simplifying bilateral treatment. Moreover, Stryker's Trevo Retriever is the first thrombectomy device to receive FDA clearance to significantly reduce disability in patients up to 24 hours from symptom onset. Until now, mechanical thrombectomy devices like the Trevo Retriever were only cleared for use up to six hours from symptom onset. However, recent randomized clinical data from the Stryker-sponsored DAWN Trial shows that patients presenting in the six- to 24-hour window who meet specific imaging criteria and are treated with the Trevo Retriever are almost four times as likely to be functionally independent at 90 days post-stroke, compared to those treated with medical management alone.

Market Segmentation

By product type, the global neurovascular thrombectomy market is segmented into aspiration thrombectomy devices, mechanical thrombectomy devices, ultrasonic thrombectomy devices and others. Mechanical thrombectomy devices are expected to be the dominant market shareholder over the period of forecast (2020-2027). Mechanical thrombectomy devices comprise a wide array of endovascular tools cleared for removing thrombi from the neurovasculature in acute ischemic stroke patients. In the US, three classes of mechanical thrombectomy devices have been cleared by the FDA: coil retrievers in 2004, aspiration devices in 2008, and stent retrievers in 2012. Mechanical thrombectomy devices work well in large, proximal arteries, rapidly debulking substantial clot burdens that are resistant to chemical fibrinolysis. While intravenous (IV) tissue-type plasminogen activator has been the only medical therapy approved by the FDA for treatment of acute stroke in the US, subgroup analyses of the National Institute of Neurologic Disorders and Stroke (NINDS) intravenous (IV) tissue-type plasminogen activator trial have shown that patients with severe strokes only have an 8% likelihood of achieving clinically significant improvement with tissue-type plasminogen activator alone. Updated acute stroke guidelines now also recommend mechanical thrombectomy in patients with acute ischemic stroke within 6–16 hours of last known normal who have large vessel occlusion in the anterior circulation. As the cases of strokes rising globally the market for mechanical thrombectomy devices is positively affected by it.

**Source: DataM Intelligence Analysis (2019)

Geographical Analysis

North America is dominating the neurovascular thrombectomy market in 2018 and estimated to hold the largest market size over the forecast period (2020-2027), owing to an increase in the prevalence of stroke, a highly aware population, advanced healthcare infrastructure, favourable government initiatives and rise in technological advancements. According to Center for Disease Control and Prevention (CDC), stroke kills about 140,000 Americans each year, that is one out of every 20 deaths. About 87% of all strokes are ischemic strokes, in which blood flow to the brain is blocked. Stroke costs US an estimated $34 billion each year. This total includes the cost of health care services, medicines to treat stroke, and missed days of work. US government provides appropriate reimbursement in case of stroke with thrombolysis. With creation of the diagnosis-related group 559, the US Centers for Medicare and Medicaid Services pays hospitals approximately US $6000 more per case when thrombolysis is administered. Most of the key market players are situated in the region, and they launch new products and invest highly in research and development in the regions such as Stryker and Johnson & Johnson.

**Source: DataM Intelligence Analysis (2019)

Competitive Landscape

Some of the major key players in the market are Johnson and Johnson, Medtronic Plc, Penumbra Inc., Stryker Corporation, Argon Medical Inc., Teleflex Incorporated, Boston Scientific Corporation, Acandis GmbH, Edwards Lifesciences Corporation, Terumo Medical Corporation and Spectranetics Corporation.

In the neurovascular thrombectomy market, Stryker Corporation is going to dominate the market, owning to portfolio expansion, mergers, collaborations, and acquisitions. The key players are adopting various growth strategies such as mergers & acquisitions, partnerships, and collaborations and increasing research and development and high investment, which are contributing to the growth of the neurovascular thrombectomy market globally.

In April 2019, Stryker announced the showcase of its new Sonopet iQ Ultrasonic Aspirator System during the American Association of Neurological Surgeons (AANS) annual meeting, taking place in San Diego, CA.  

In September 2018, Penumbra, Inc. announced U.S. commercial availability of Penumbra JET 7 and Penumbra JET D Reperfusion Catheters powered by the Penumbra ENGINE aspiration source. All are part of the fully integrated Penumbra System® that utilizes aspiration-based mechanical thrombectomy for stroke revascularization.

In May 2018, Johnson and Johnson announced that its next-generation stent retriever to capture and remove blood clots from the brain in patients with ischemic stroke had received 510(k) clearance from the FDA.

In February 2018, Stryker’s Trevo® Retriever became first and the only device indicated for treatment up to 24 hours, aligning with new AHA/ASA guidelines

Why Purchase the Report?

  • Visualize the composition of the Neurovascular Thrombectomy market across each indication, in terms of type and by type highlighting the key commercial assets and players.

  • Identify commercial opportunities in Neurovascular Thrombectomy by analyzing trends and co-development deals.

  • Excel data sheets with thousands of data points of Neurovascular Thrombectomy market- level 4/5 segmentation.

  • PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.

  • Product mapping in excel for the key products of all major market players.

The Global Neurovascular Thrombectomy Market report would provide an access to an approx., 53 market data table, 43 figures, and 200 pages.

Target Audience

  • Service Providers/ Buyers

  • Industry Investors/Investment Bankers

  • Education & Research Institutes

  • Research Professionals

  • Emerging Companies

  • Manufacturers

 

Table of Contents

  1. Neurovascular Thrombectomy Devices Market Methodology and Scope

    1. Research Methodology
    2. Research Objective and Scope of the Report
  2. Neurovascular Thrombectomy Devices Market – Market Definition and Overview

  3. Neurovascular Thrombectomy Devices Market – Executive Summary

    1.  Market Snippet by Product Type
    2. Market Snippet by End User
    3. Market Snippet by Region
    4. DataM CLO Scenario
  4. Neurovascular Thrombectomy Devices Market-Market Dynamics

    1. Market Impacting Factors
    2. Drivers
      1. Rising prevalence of ischemic stroke
      2. Technological advancement
    3. Restraints
      1. Lack of awareness
    4. Opportunity
    5. Impact Analysis
  5. Neurovascular Thrombectomy Devices Market – Industry Analysis

    1. Porter's Five Forces Analysis
    2.  Supply Chain Analysis
    3. Regulatory Analysis
    4. Epidemiology
  6. Neurovascular Thrombectomy Devices Market – By Product Type

    1. Introduction
      1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
      2. Market Attractiveness Index, By Product Type
    2. Aspiration Thrombectomy Devices
      1. Introduction
      2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
    3. Mechanical Thrombectomy Devices
    4. Ultrasonic Thrombectomy Devices
    5. Others
  7. Neurovascular Thrombectomy Devices Market – By End User

    1. Introduction
      1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
      2. Market Attractiveness Index, By End User
    2. Hospitals
      1. Introduction
      2. Market Size Analysis, and Y-o-Y Growth Analysis (%), 2018-2026
    3.  Neuro-Catheterization Labs
    4.  Specialized Neurosurgery Centers
  8. Neurovascular Thrombectomy Devices Market – By Region

    1. Introduction
    2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
    3. Market Attractiveness Index, By Region
    4. North America
      1. Introduction
      2. Key Region-Specific Dynamics
      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
        1. U.S.
        2. Canada
        3. Mexico
    5. Europe
      1. Introduction
      2. Key Region-Specific Dynamics
      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
        1. Germany
        2. U.K.
        3. France
        4. Italy
        5. Spain
        6. Rest of Europe
    6. South America
      1. Introduction
      2. Key Region-Specific Dynamics
      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
        1. Brazil
        2. Argentina
        3. Rest of South America
    7. Asia-Pacific
      1. Introduction
      2. Key Region-Specific Dynamics
      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
        1. China
        2. India
        3. Japan
        4. Australia
        5. Rest of Asia Pacific
    8. The Middle East and Africa
      1. Introduction
      2. Key Region-Specific Dynamics
      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
  9. Market – Competitive Landscape

    1. Competitive Scenario
    2. Competitor Neurovascular Thrombectomy Devices Strategy Analysis
    3. Comparative Product Portfolio Analysis
    4. Market Positioning/Share Analysis
    5. Mergers and Acquisitions Analysis
  10. Company Profiles

    1. Johnson and Johnson *
      1. Company Overview
      2. Product Portfolio and Description
      3. Key Highlights
      4. Financial Overview
    2. Medtronic Plc
    3. Penumbra Inc.
    4. Stryker Corporation
    5. Argon Medical Inc.
    6. Teleflex Incorporated
    7. Boston Scientific Corporation
    8. Acandis GmbH
    9. Edwards Lifesciences Corporation
    10. Terumo Medical Corporation
    11. Spectranetics Corporation ("List not exhaustive")
  11. Neurovascular Thrombectomy Devices Market – Premium Insights

  12. Neurovascular Thrombectomy Devices Market – DataM

    1. Appendix
    2. About Us and Services
    3. Contact Us

List of Tables and Figures

List of Tables

Table 1 Global Neurovascular Thrombectomy Devices Market Value, By Product Type, 2018,2022 & 2027 ($ Million)

Table 2 Global Neurovascular Thrombectomy Devices Market Value, By End User, 2018,2022 & 2027 ($ Million)

Table 3 Global Neurovascular Thrombectomy Devices Market Value, By Region, 2018,2022 & 2027 ($ Million)

Table 4 Global Neurovascular Thrombectomy Devices Market Value, By Product Type, 2018,2022 & 2027 ($ Million)

Table 5 Global Neurovascular Thrombectomy Devices Market Value, By Product Type, 2017-2027 ($ Million)

Table 6 Global Neurovascular Thrombectomy Devices Market Value, By End User, 2018,2022 & 2027 ($ Million)

Table 7 Global Neurovascular Thrombectomy Devices Market Value, By End User, 2017-2027 ($ Million)

Table 8 Global Neurovascular Thrombectomy Devices Market Value, By Region, 2018,2022 & 2027 ($ Million)

Table 9 Global Neurovascular Thrombectomy Devices Market Value, By Region, 2017-2027 ($ Million)

Table 10 North America Neurovascular Thrombectomy Devices Market Value, By Product Type, 2017-2027 ($ Million)

Table 11 North America Neurovascular Thrombectomy Devices Market Value, By End User, 2017-2027 ($ Million)

Table 12 North America Neurovascular Thrombectomy Devices Market Value, By Country, 2017-2027 ($ Million)

Table 13 South America Neurovascular Thrombectomy Devices Market Value, By Product Type, 2017-2027 ($ Million)

Table 14 South America Neurovascular Thrombectomy Devices Market Value, By End User, 2017-2027 ($ Million)

Table 15 South America Neurovascular Thrombectomy Devices Market Value, By Country, 2017-2027 ($ Million)

Table 16 Europe Neurovascular Thrombectomy Devices Market Value, By Product Type, 2017-2027 ($ Million)

Table 17 Europe Neurovascular Thrombectomy Devices Market Value, By End User, 2017-2027 ($ Million)

Table 18 Europe Neurovascular Thrombectomy Devices Market Value, By Country, 2017-2027 ($ Million)

Table 19 Asia-Pacific Neurovascular Thrombectomy Devices Market Value, By Product Type, 2017-2027 ($ Million)

Table 20 Asia-Pacific Neurovascular Thrombectomy Devices Market Value, By End User, 2017-2027 ($ Million)

Table 21 Asia-Pacific Neurovascular Thrombectomy Devices Market Value, By Country, 2017-2027 ($ Million)

Table 22 Middle East & Africa Neurovascular Thrombectomy Devices Market Value, By Product Type, 2017-2027 ($ Million)

Table 23 Middle East & Africa Neurovascular Thrombectomy Devices Market Value, By End User, 2017-2027 ($ Million)

Table 24 Johnson and Johnson: Overview

Table 25 Johnson and Johnson: Product Portfolio

Table 26 Johnson and Johnson: Key Developments

Table 27 Medtronic Plc: Overview

Table 28 Medtronic Plc: Product Portfolio

Table 29 Medtronic Plc: Key Developments

Table 30 Penumbra Inc.: Overview

Table 31 Penumbra Inc.: Product Portfolio

Table 32 Penumbra Inc.: Key Developments

Table 33 Stryker Corporation: Overview

Table 34 Stryker Corporation: Product Portfolio

Table 35 Stryker Corporation: Key Developments

Table 36 Argon Medical Inc.: Overview

Table 37 Argon Medical Inc.: Product Portfolio

Table 38 Argon Medical Inc.: Key Developments

Table 39 Teleflex Incorporated: Overview

Table 40 Teleflex Incorporated: Product Portfolio

Table 41 Teleflex Incorporated: Key Developments

Table 42 Boston Scientific Corporation: Overview

Table 43 Boston Scientific Corporation: Product Portfolio

Table 44 Boston Scientific Corporation: Key Developments

Table 45 Acandis GmbH: Overview

Table 46 Acandis GmbH: Product Portfolio

Table 47 Acandis GmbH: Key Developments

Table 48 Edwards Lifesciences Corporation: Overview

Table 49 Edwards Lifesciences Corporation: Product Portfolio

Table 50 Edwards Lifesciences Corporation: Key Developments

Table 51 Terumo Medical Corporation: Overview

Table 52 Terumo Medical Corporation: Product Portfolio

Table 53 Terumo Medical Corporation: Key Developments

 

 List of Figures

Figure 1 Global Neurovascular Thrombectomy Devices Market Share, By Product Type, 2018 & 2027 (%)

Figure 2 Global Neurovascular Thrombectomy Devices Market Share, By End User, 2018 & 2027 (%)

Figure 3 Global Neurovascular Thrombectomy Devices Market Share, By Region, 2018 & 2027 (%)

Figure 4 Global Neurovascular Thrombectomy Devices Market Value, 2017-2027 ($ Million)

Figure 5 Global Neurovascular Thrombectomy Devices Market Y-o-Y Growth, By Product Type, 2018-2027 (%)

Figure 6 Aspiration Thrombectomy Devices: Global Neurovascular Thrombectomy Devices Market Value, 2017-2027 ($ Million)

Figure 7 Mechanical Thrombectomy Devices: Global Neurovascular Thrombectomy Devices Market Value, 2017-2027 ($ Million)

Figure 8 Ultrasonic Thrombectomy Devices: Global Neurovascular Thrombectomy Devices Market Value, 2017-2027 ($ Million)

Figure 9 Others: Global Neurovascular Thrombectomy Devices Market Value, 2017-2027 ($ Million)

Figure 10 Global Neurovascular Thrombectomy Devices Market Y-o-Y Growth, By End User, 2018-2027 (%)

Figure 11 Hospitals: Global Neurovascular Thrombectomy Devices Market Value, 2017-2027 ($ Million)

Figure 12 Neuro-Catheterization Labs: Global Neurovascular Thrombectomy Devices Market Value, 2017-2027 ($ Million)

Figure 13 Specialized Neurosurgery Centers: Global Neurovascular Thrombectomy Devices Market Value, 2017-2027 ($ Million)

Figure 14 Global Neurovascular Thrombectomy Devices Market Y-o-Y Growth, By Region, 2018-2027 (%)

Figure 15 North America Neurovascular Thrombectomy Devices Market Value, 2017-2027 ($ Million)

Figure 16 North America Neurovascular Thrombectomy Devices Market Share, By Product Type, 2018 & 2027 (%)

Figure 17 North America Neurovascular Thrombectomy Devices Market Share, By End User, 2018 & 2027 (%)

Figure 18 North America Neurovascular Thrombectomy Devices Market Share, By Country, 2018 & 2027 (%)

Figure 19 South America Neurovascular Thrombectomy Devices Market Value, 2017-2027 ($ Million)

Figure 20 South America Neurovascular Thrombectomy Devices Market Share, By Product Type, 2018 & 2027 (%)

Figure 21 South America Neurovascular Thrombectomy Devices Market Share, By End User, 2018 & 2027 (%)

Figure 22 South America Neurovascular Thrombectomy Devices Market Share, By Country, 2018 & 2027 (%)

Figure 23 Europe Neurovascular Thrombectomy Devices Market Value, 2017-2027 ($ Million)

Figure 24 Europe Neurovascular Thrombectomy Devices Market Share, By Product Type, 2018 & 2027 (%)

Figure 25 Europe Neurovascular Thrombectomy Devices Market Share, By End User, 2018 & 2027 (%)

Figure 26 Europe Neurovascular Thrombectomy Devices Market Share, By Country, 2018 & 2027 (%)

Figure 27 Asia-Pacific Neurovascular Thrombectomy Devices Market Value, 2017-2027 ($ Million)

Figure 28 Asia-Pacific Neurovascular Thrombectomy Devices Market Share, By Product Type, 2018 & 2027 (%)

Figure 29 Asia-Pacific Neurovascular Thrombectomy Devices Market Share, By End User, 2018 & 2027 (%)

Figure 30 Asia-Pacific Neurovascular Thrombectomy Devices Market Share, By Country, 2018 & 2027 (%)

Figure 31 Middle East & Africa Neurovascular Thrombectomy Devices Market Value, 2017-2027 ($ Million)

Figure 32 Middle East & Africa Neurovascular Thrombectomy Devices Market Share, By Product Type, 2018 & 2027 (%)

Figure 33 Middle East & Africa Neurovascular Thrombectomy Devices Market Share, By End User, 2018 & 2027 (%)

Figure 34 Johnson and Johnson: Financials

Figure 35 Medtronic Plc: Financials

Figure 36 Penumbra Inc.: Financials

Figure 37 Stryker Corporation: Financials

Figure 38 Argon Medical Inc.: Financials

Figure 39 Teleflex Incorporated: Financials

Figure 40 Boston Scientific Corporation: Financials

Figure 41 Acandis GmbH: Financials

Figure 42 Edwards Lifesciences Corporation: Financials

Figure 43 Terumo Medical Corporation: Financials

Did not find what you were looking for?Every 7 out of 10 customers request tailored reports. Get yours today!
We collate your requirements.
Our global research team is put into action.
We deliver, and make sure your endeavour is a success!

Buy This Report



Get your FREE SAMPLE PROPOSAL with a single click!

linkedinpinterest